Outlook Therapeutics (OTLK) Selling, General & Administrative (2015 - 2026)
Outlook Therapeutics (OTLK) posted Selling, General & Administrative of $7.55 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 22.0% from $9.68 million a year earlier and down 20.6% from the prior quarter.
Outlook Therapeutics (OTLK) Selling, General & Administrative (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Outlook Therapeutics was $36 million, down 9.9% year-over-year; for FY2025 (ended Sep 30, 2025), it was $39.94 million, up 33.4% from FY2024.
- Annual Selling, General & Administrative has increased for six consecutive fiscal years, with a five-year compound annual growth rate of 32.0% (FY2020 to FY2025).
- In prior fiscal years, Outlook Therapeutics' Selling, General & Administrative was $29.94 million in FY2024 (+12.2%), $26.67 million in FY2023 (+28.6%), $20.74 million in FY2022 (+62.4%) and $12.77 million in FY2021 (+28.1%).
- The fiscal Q3 2026 figure stands as the lowest quarterly Selling, General & Administrative since fiscal Q2 2024.
- On a year-over-year basis, Selling, General & Administrative increased in five of the last eight quarters, with growth averaging 22.0%.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was fiscal Q1 2025, with growth of 106.2%; the weakest was fiscal Q1 2026, with a decline of 27.9%.
- According to Business Quant data, Selling, General & Administrative for the three prior fiscal quarters was $9.5 million (Q2 2026), $8.61 million (Q1 2026) and $10.33 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Outlook Therapeutics | 80.68 Mn | 44.93 Mn | -8,265.00 | 7.55 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.55 Mn |
| Mar 31, 2026 | 9.50 Mn |
| Dec 31, 2025 | 8.61 Mn |
| Sep 30, 2025 | 10.33 Mn |
| Jun 30, 2025 | 9.68 Mn |
| Mar 31, 2025 | 7.98 Mn |
| Dec 31, 2024 | 11.95 Mn |
| Sep 30, 2024 | 10.35 Mn |
| Jun 30, 2024 | 8.36 Mn |
| Mar 31, 2024 | 5.43 Mn |
| Dec 31, 2023 | 5.79 Mn |
| Sep 30, 2023 | 7.51 Mn |
| Jun 30, 2023 | 7.04 Mn |
| Mar 31, 2023 | 6.29 Mn |
| Dec 31, 2022 | 5.83 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 5.77 Mn |
| Mar 31, 2022 | 6.69 Mn |
| Dec 31, 2021 | 3.28 Mn |
| Sep 30, 2021 | 3.50 Mn |
Outlook Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();